[1. Counterfeit medicines: a public health challenge. WHO. January 2010, http://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products.]Search in Google Scholar
[2. IMPACT International Medical Products Anti-counterfeiting Taskforce. The Handbook. Facts, Activities, Documents Developed by the Assembly and the Working Groups, 2006-2010 (2011; 164 pages) http://apps.who.int/medicinedocs/en/m/abstract/Js20967en/.]Search in Google Scholar
[3. International Medical Products Anti-counterfeiting Taskforce, Principles and Elements for National Legislation against Counterfeit Medical Products. Text endorsed by IMPACT General Meeting. Lisbon, 12 December 2007 http://apps.who.int/medicinedocs/documents/s20967en/s20967en.pdf.]Search in Google Scholar
[4. Preliminary Draft Survey on national legislation on “Counterfeit medicines”, Working document WHO/ACM/1, 4 may 2010. https://www.who.int/medicines/services/counterfeit/WHO_ACM_Report.pdf.]Search in Google Scholar
[5. Hristov EI, Kulaksazova RJ. Bulgarian Drug Agency experience with counterfeit medicines. Oral report. 53 meeting of Heads of Medicine Agencies, Brdo, Slovenia, 13-14.04.2008.]Search in Google Scholar
[6. Hristov EI, Kulaksazova RJ. Counterfeit medicinal products-Introduction in theory and practice. Oral report. Pharmaceutical Fourth Symposium on Southeast Europe. EGA, Istanbul, Turkey, 2008.]Search in Google Scholar
[7. Hristov EI, Spassova SS. Bulgaria tackles increasing numbers of counterfeit drugs. Pharmaceutical Dialogue. German Association of Pharmaceutical Parallel Distributors, 2010;12(4):4.]Search in Google Scholar
[8. Hristov EI, Dimitrova ZD, Parvova IA et al. Scientific, Regulatory and Practical Approaches to the Fight against Counterfeit Medicinal Products. Bul Exp J US-China Med Sci, 2016; (13):1-12.10.17265/1548-6648/2016.01.001]Search in Google Scholar
[9. Resolution on Counterfeiting Medicinal Products. European Parliament, September 2006. http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B6-2006-0483&language=EN.]Search in Google Scholar
[10. European Parliament. (Brussels 14 May 2007), First European Parliamentary Symposium on Pharmaceuticals, Putting an End to Drug Counterfeiting. www.epp-ed.eu/Press/peve07/docs/070514programme_pharmaceuticals_en%20.pdf.]Search in Google Scholar
[11. Summary of the Impact Assessment, Commission staff working document: Accompanying document to the Proposal for a Directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of medicinal products which are falsified in relation to their identity, history or source. SEC (2008) 2674, Brussels, 10 Dec 2008. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A52014SC0208,.]Search in Google Scholar
[12. Impact Assessment, Commission staff working document: Accompanying document to the Proposal for a Directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of medicinal products which are falsified in relation to their identity, history or source. SEC (2008) 2674, Brussels, 10 Dec 2008. https://eur-lex.europa.eu/legal-content/BG/TXT/?uri=CELEX:52016SC0410.]Search in Google Scholar
[13. Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products. https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32011L0062.]Search in Google Scholar
[14. Commission delegated regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32016R0161].]Search in Google Scholar
[15. National register of BPhU, https://bphu.bg/19_РЕГИСТЪР/22_София-столична.htm?search:13.]Search in Google Scholar
[16. Medicines verification system goes live across EU to better protect patients from falsified medicines, https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/medicines-verification-system-goes-live-across-eu-to-better-protect-patients-from-falsified-medicines/.]Search in Google Scholar
[17. Official start of Bulgarian medicines verification system, https://www.bgmvo.org/en/single-new/51/.]Search in Google Scholar
